(Q35167706)

6 August 2017

1 reference

title

Old dogs and new tricks: proteases, inhibitors, and cell migration (English)

1 reference

6 August 2017

1 reference

Steingrimur Stefansson

series ordinal

1

1 reference

PubMed ID

12837933

6 August 2017

Daniel A Lawrence

series ordinal

2

1 reference

PubMed ID

12837933

6 August 2017

language of work or name

1 reference

1 July 2003

1 reference

Science's STKE : signal transduction knowledge environment

6 August 2017

1 reference

6 August 2017

2003

1 reference

6 August 2017

189

1 reference

6 August 2017

pe24

1 reference

Integrins: bidirectional, allosteric signaling machines

6 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

The cell adhesion domain in plasma vitronectin is cryptic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Membrane microdomains and caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Fibrinolysis: Past and Present, a Reflection of Fifty Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Fibrillar collagen regulation of plasminogen activator inhibitor-1 is involved in altered smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Conformational lability of vitronectin: induction of an antigenic change by alpha-thrombin-serpin complexes and by proteolytically modified thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.189.PE24

10.1126/STKE.2003.189.PE24

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12837933